JONATHAN M. METSCH, Dr.P.H. – Tracking Emerging Public Health Challenges – October 24, 2026– PLAGUE
“That is not how you respond to garden-variety pneumonia — and it isn’t really how you’d respond to ordinary plague either, which has been curable with cheap antibiotics for decades,” Dr. Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, said.
Even without confirmation of the pathogen, however, the shape of spread is the most important factor to watch. “Pandemic potential shows up as a growing chain of human-to-human transmission, and that is not what we’re seeing,” he said.
Adalja said no cluster of severe illness had developed among nearly 200 people who The Moscow Times reported were placed under medical observation.
Hayley Anne Severance, deputy vice president for the Nuclear Threat Initiative’s global biological policy and programs, said she needed more information before providing a global health risk assessment.
“I am still in ‘wait-and-see’ mode,” Severance said. “We need to know more about laboratory test findings, the treatments provided and her reaction to them, and any other potential exposure factors. We do not have confirmation of the causative agent, or if there even is an infectious agent involved, so we are flying in the dark here.”
Experts are watching Russian authorities, local media for reports of more cases
Currently, about 10 days after the researcher’s death, there have been no secondary cases confirmed in connection with the lab worker’s death.
“If this were a fast-spreading cluster, the window in which we’d expect to see it has basically passed,” Adalja told Well Informed on Oct. 8.
Other concerns would include expanding quarantine measures and Russian authorities refusing outside investigators or blocking a WHO team, Adalja said.
Local media reports could also offer clues, Severance said.
“I would be concerned if I begin to see reports from independent news outlets in Russia that there are unreported cases or deaths ongoing in the region that are not being acknowledged or confirmed by official Russian sources,” she said.
Standard pneumonic plague isn’t a significant pandemic threat
Pneumonic plague occurs when someone inhales respiratory droplets that contain the bacteria Yersinia pestis — or when the bacteria causing bubonic or septicemic plague spreads to the lungs.
It can be treated with antibiotics. Without prompt treatment, pneumonic plague has “a nearly 100% case-fatality rate,” according to the U.S. Centers for Disease Control and Prevention.
It is the only plague that can spread person to person, usually with prolonged contact.
Measures such as masking could decrease disease spread. Pneumonic plague’s incubation period is short — about one to four days — so it’s less likely infected people would spread disease unknowingly, Severance said.
“In past pneumonic plague outbreaks, on average, each infected person spread to between one and two others,” and that dropped quickly with isolation measures, Severance said.” (2)
“Earlier this year, the hantavirus outbreak originating on the MV Hondius cruise ship was successfully contained, showing that the global health system can still work well when countries cooperate. This latest incident suggests that one recalcitrant nation can jeopardise everyone’s safety. It is not the WHO’s fault that Russia is essentially a rogue state, but the body must be ready for such eventualities. International politics is fragmented, and only becoming more so.”
“The keen US interest may give credence to speculation that what in fact happened was some kind of bioweapons research leak. This is thought to be unlikely, but not impossible. The fact that such a scenario can even be plausibly entertained three weeks after the initial event speaks to a serious breakdown in the system. Western states probably do not hold much sway with Russia. But the other Brics nations may have more. The WHO used to rely on US backing for its requests. It may now have to find support among wider, more multipolar coalitions. This potential outbreak may come to nothing, but there will be another soon.” (3)
“Predictably the story emerging from Russia was conflicting accounts that denied that there was a death from any form of plague. Russia told the World Health Organisation (WHO) her death was pneumonia of unknown origin, not pneumonic plague. Later Russia wound down its precautions, saying there was no epidemic risk. They haven’t published autopsy details, any laboratory report or commission findings.”
“That, in the end, is the lesson of the long history of plague. The disease is fearsome, but ignorance and secrecy have always made it worse. There is no sign that Siberia is facing a new Black Death. But a young scientist is dead, and her family and the rest of us deserve a straight answer about why. The bacterium has been beaten back, though not beaten. What keeps it in check is medicine, transparency and honesty.” (4)
“There are actions we can take now:
We need better lab safety in every country. The number of labs that work with dangerous pathogens has increased worldwide over two decades, but there’s no enforceable international standard and no inspection regime; the Biological Weapons Convention, fifty years on, still has no verification mechanism. Labs that study dangerous germs need strong safety systems, training, and oversight.
We need to reduce spillover events. Three in four emerging human infections start in animals, and there’s a lot we can do to reduce spillover risk, but the world is doing very little of it. Live-animal markets are one place to act. For instance, closing live-bird markets helped control H7N9 influenza in China. Reducing opportunities for people to encounter infected animals can prevent infections before they become outbreaks.
In The Formula for Better Health, which is now out in paperback along with the hardcover, Kindle, and audiobook versions, I argue that labs do too many risky experiments with too many dangerous pathogens in too many institutions, and that every experiment should first answer one basic question: Is the likely benefit greater than the risk? Spillover risk can also be reduced: In the book, I discuss how Brazil cut its deforestation rate by 70% from 2004 to 2012 while increasing agricultural production and reducing risky contact between people and forest animals.
We need faster detection and response. Delay costs lives. Strong surveillance, good labs, and trained responders can turn a single case into a small cluster of infections instead of an epidemic.” (5)
The Black Plague Returns, https://harvardindependent.com/the-black-plague-returns/
“This case offers an opportunity to revisit the microbiology, clinical presentation, treatment, prevention and epidemiology of plague—and why diagnostic preparedness remains essential in an interconnected world.
1.What are the microbiological characteristics of the pathogen?
2. Are there any challenges in diagnosing the plague?
3. What treatment and prevention options are available?
4. What did the Russian response tell us?
5. What does Irkutsk mean for global health? (6)
1.Moscow Declares Plague Lab Death Case ‘Closed’ — but Nobody Is Saying What Killed Darya Shipilova, by HOLLIE McKAY, https://www.nysun.com/article/moscow-declares-plague-lab-death-case-closed-but-nobody-is-saying-what-killed-darya-shipilova
2.Does a Russian lab worker’s death carry pandemic risk? Experts say it’s unlikely, with one caveat, by Madison Czopek, https://www.pbs.org/newshour/health/does-a-russian-lab-workers-death-carry-pandemic-risk-experts-say-its-unlikely-with-one-caveat
3.The Guardian view on plague in Russia: what is most worrying is the lack of information Editorial, https://www.theguardian.com/commentisfree/2026/oct/18/the-guardian-view-on-plague-in-russia-what-is-most-worrying-is-the-lack-of-information
4.Scientist’s death raises troubling plague questions, By James Williams, https://www.theargus.co.uk/news/26654671.scientists-death-raises-troubling-plague-questions/
5.Plague is stoppable. The next health threat may not be., by Tom Frieden, https://tomfrieden.substack.com/p/plague-is-stoppable-the-next-health
6.Five questions about the pneumonic plague concerns in Russia answered by a TXST microbiology and virology specialist, by Rodney E. Rohde, https://news.txst.edu/faculty-experts/2026/five-questions-about-the-pneumonic-plague-concerns-in-russia.html
curated by Jonathan M. Metsch, Dr.P.H.
Clinical Professor of Environmental Medicine, Icahn School of Medicine at Mount Sinai